Cardiovascular Pharmacology in Special Populations

The pharmacological management of cardiovascular diseases in special populations, such as the elderly, women, and patients with comorbid conditions, requires tailored approaches due to differences in drug metabolism, disease pathophysiology, and therapeutic responses. This session will explore the unique challenges in prescribing cardiovascular drugs for these groups, focusing on factors like polypharmacy, age-related changes in pharmacokinetics, and hormonal influences on drug efficacy and safety. Key topics will include gender differences in cardiovascular disease progression and response to treatments, the management of hypertension and heart failure in the elderly, and considerations for patients with diabetes, kidney disease, or pregnancy-related conditions. We will also discuss emerging therapies and strategies to improve cardiovascular care for underserved and high-risk populations.

    Related Conference of Cardiovascular Pharmacology in Special Populations

    July 27-28, 2026

    19th World Drug Delivery Summit

    Paris, France
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 14-15, 2026

    6th International Conference on Pharmaceutical Chemistry

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    December 14-15, 2026

    5th Global Summit on Pharmaceutical Research

    Paris, France
    January 26-27, 2027

    22nd Annual Meet on Pharmaceutical Sciences

    Paris, France
    April 27-28, 2027

    10th European Biopharma Congress

    Paris, France

    Cardiovascular Pharmacology in Special Populations Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in